Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
A study of people with obstructive sleep apnea suggests that high CPAP pressures may explain why the machines do not lower a patient’s risk of heart disease.
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.
Columbia researcher Jon Giles has published research showing a link between atherosclerosis and depressive symptoms, stress, anxiety, anger, and lack of social support in patients with rheumatoid arthritis.
Columbia research shows that expanding treatment of high blood pressure with cost-effective medication could prevent 1 million heart attacks and strokes in China.
Nanometer-sized “drones” that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis.
Using the same technology that made smartphone cameras possible, Columbia scientists are capturing images of molecules at a level of detail never before possible.